Reanalysis of the Multi‐Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic‐Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al

Saved in:
Bibliographic Details
Published inArthritis & rheumatology (Hoboken, N.J.) Vol. 69; no. 4; pp. 863 - 865
Main Authors Curtis, Jeffrey R., Wright, Grace C., Strand, Vibeke, Davis, Charles S., Hitraya, Elena, Sasso, Eric H.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.04.2017
John Wiley and Sons Inc
Subjects
Abatacept
Adalimumab
Antirheumatic Agents
Arthritis
Arthritis, Rheumatoid
Biological Products
Biomarkers
Humans
Immunotherapy
Letters
Methotrexate
Monoclonal antibodies
Rheumatoid arthritis
TNF inhibitors
Online AccessGet full text
ISSN2326-5191
2326-5205
2326-5205
DOI10.1002/art.39981

Cover

Author Davis, Charles S.
Sasso, Eric H.
Curtis, Jeffrey R.
Strand, Vibeke
Hitraya, Elena
Wright, Grace C.
AuthorAffiliation 3 Stanford University School of Medicine Stanford CA
4 CSD Biostatistics, Inc. Oro Valley AZ
2 New York University Langone Medical Center New York NY
1 University of Alabama at Birmingham
5 Crescendo Bioscience South San Francisco CA
AuthorAffiliation_xml – name: 3 Stanford University School of Medicine Stanford CA
– name: 2 New York University Langone Medical Center New York NY
– name: 4 CSD Biostatistics, Inc. Oro Valley AZ
– name: 1 University of Alabama at Birmingham
– name: 5 Crescendo Bioscience South San Francisco CA
Author_xml – sequence: 1
  givenname: Jeffrey R.
  surname: Curtis
  fullname: Curtis, Jeffrey R.
  organization: University of Alabama at Birmingham
– sequence: 2
  givenname: Grace C.
  surname: Wright
  fullname: Wright, Grace C.
  organization: New York University Langone Medical Center
– sequence: 3
  givenname: Vibeke
  surname: Strand
  fullname: Strand, Vibeke
  organization: Stanford University School of Medicine
– sequence: 4
  givenname: Charles S.
  surname: Davis
  fullname: Davis, Charles S.
  organization: CSD Biostatistics, Inc
– sequence: 5
  givenname: Elena
  surname: Hitraya
  fullname: Hitraya, Elena
  organization: Crescendo Bioscience
– sequence: 6
  givenname: Eric H.
  surname: Sasso
  fullname: Sasso, Eric H.
  organization: Crescendo Bioscience
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27813312$$D View this record in MEDLINE/PubMed
BookMark eNp9ks1u1DAUhQMqomXoghdAltjAYlo7_-kCKS0UkFqQpoWtdePcTDx14sF2WrLjEXhGngRPZwZB-cnGkfzdc8-9Po-CnV73GARPGD1glIaHYNxBVBQ5ux_shVGYTpOQJjvbf1aw3WDf2gX1X5HRlCYPg90wy1kUsXDv3t4MoQc1WmmJbohrkZwPysnvX78dS92BuUJDXkmLYJGUwslr6UZyIbRB0mhDSmvRWtnP_4RkfytXVuBA4NKRT2jsYElZg5Ld0EFFTnS3BCOt7le0b6j0XArf-z3IaySzFj3mtKxJaVxrpPMuL4ZqgcJZciNdS45BXM2NHvqanKNrtTP4BRySCzfU49GqQYe9I3rjxTgpFJJqJKcKpRVtB31P0BFQj4MHDSiL-5tzEnw8fX158nZ69uHNu5PybCrijLFplNd1BBTqhMYUMpEmokhRxFHcVHkRpVkWZnERY5T4_UYZZglUWDcFRBlr_N6jSfByrbscqg5r4e0ZUHxppN_2yDVI_vtNL1s-19c89bpFzLzA842A0Z8HtI53fhJUCnrUg-Us9y7CLPQOJsGzO-hCD8a_t-VhWNA0LlLK_kexPGfes5_LU09_9f3T8DZLHjhcA8Joaw02XEgHTurVGFJxRvkqsNwHlt8G1le8uFOxFf0bu1G_kQrHf4O8nF2uK34AoF0AbA
CitedBy_id crossref_primary_10_1186_s13075_018_1750_5
crossref_primary_10_1097_RHU_0000000000000937
crossref_primary_10_1186_s13075_020_02163_6
crossref_primary_10_3892_etm_2018_5973
crossref_primary_10_1080_03007995_2019_1585064
crossref_primary_10_3390_cells7100161
crossref_primary_10_1186_s13075_020_02389_4
crossref_primary_10_1093_rheumatology_keac715
crossref_primary_10_3899_jrheum_190603
Cites_doi 10.1093/rheumatology/keg072
10.1002/art.39274
10.1016/j.jpba.2012.06.003
10.1136/annrheumdis-2013-204986
10.1093/rheumatology/kes378
10.1002/acr.21767
10.1002/art.1780380107
10.1136/rmdopen-2015-000197
10.1136/ard.2006.054205
10.1136/annrheumdis-2011-200963
10.3109/14397595.2016.1153449
10.1186/ar1740
10.3899/jrheum.131412
10.1093/rheumatology/kev341
10.1093/rheumatology/kes362
10.3899/jrheum.081018
10.1136/annrheumdis-2013-204920
10.1002/art.37711
10.1136/annrheumdis-2013-203843
ContentType Journal Article
Copyright 2016, American College of Rheumatology
2017, American College of Rheumatology
2016 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology.
Copyright_xml – notice: 2016, American College of Rheumatology
– notice: 2017, American College of Rheumatology
– notice: 2016 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7T5
7TM
7U7
C1K
H94
K9.
7X8
5PM
DOI 10.1002/art.39981
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Nucleic Acids Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Toxicology Abstracts
Bacteriology Abstracts (Microbiology B)
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Calcium & Calcified Tissue Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate LETTERS
EISSN 2326-5205
EndPage 865
ExternalDocumentID PMC6749941
4321261025
27813312
10_1002_art_39981
ART39981
Genre letter
Letter
Comment
Commentary
Correspondence
GroupedDBID 0R~
1OC
24P
33P
3SF
4.4
52O
52U
52V
53G
5VS
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAQQT
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCUV
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AZFZN
AZVAB
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
DCZOG
DIK
DRFUL
DRMAN
DRSTM
EBS
EJD
EMOBN
EX3
F00
FUBAC
G-S
G.N
GODZA
HGLYW
KBYEO
LATKE
LEEKS
LH4
LITHE
LOXES
LUTES
LW6
LYRES
MEWTI
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
NF~
O66
O9-
OK1
OVD
P2W
PQQKQ
QB0
ROL
SUPJJ
SV3
TEORI
V9Y
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WVDHM
WXSBR
YCJ
AAFWJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7T5
7TM
7U7
C1K
H94
K9.
7X8
5PM
ID FETCH-LOGICAL-c4711-38dd3a0ad5040a7c65c96ec434fb89367727494e3531237e75abedf9a371f2783
IEDL.DBID 24P
ISSN 2326-5191
2326-5205
IngestDate Thu Aug 21 18:14:52 EDT 2025
Fri Jul 11 09:39:26 EDT 2025
Fri Jul 25 12:11:32 EDT 2025
Fri Jul 25 12:16:46 EDT 2025
Mon Jul 21 06:07:21 EDT 2025
Thu Apr 24 23:06:53 EDT 2025
Tue Jul 01 00:55:52 EDT 2025
Wed Jan 22 17:12:37 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License http://creativecommons.org/licenses/by/4.0
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4711-38dd3a0ad5040a7c65c96ec434fb89367727494e3531237e75abedf9a371f2783
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Correspondence-1
ObjectType-Commentary-2
content type line 23
The copyright line for this article was changed on 16 September 2019 after original online publication.
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fart.39981
PMID 27813312
PQID 1881783936
PQPubID 946334
PageCount 3
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6749941
proquest_miscellaneous_1836727235
proquest_journals_2290649601
proquest_journals_1881783936
pubmed_primary_27813312
crossref_citationtrail_10_1002_art_39981
crossref_primary_10_1002_art_39981
wiley_primary_10_1002_art_39981_ART39981
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate April 2017
PublicationDateYYYYMMDD 2017-04-01
PublicationDate_xml – month: 04
  year: 2017
  text: April 2017
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Atlanta
– name: Hoboken
PublicationTitle Arthritis & rheumatology (Hoboken, N.J.)
PublicationTitleAlternate Arthritis Rheumatol
PublicationYear 2017
Publisher Wiley Subscription Services, Inc
John Wiley and Sons Inc
Publisher_xml – name: Wiley Subscription Services, Inc
– name: John Wiley and Sons Inc
References 2009; 67
2012; 71
2015; 67
2009; 36
2012; 70
2015; 5
2016; 2
2013; 65
1995; 38
2015; 74
1999; 26
2013; 52
2005; 7
2016
2014; 41
2014; 73
2007; 66
2003; 42
2016; 68
2012; 64
2016; 55
e_1_2_2_4_1
e_1_2_2_25_1
e_1_2_2_5_1
Hirata S (e_1_2_2_24_1) 2015; 5
e_1_2_2_23_1
e_1_2_2_22_1
e_1_2_2_20_1
e_1_2_2_2_1
e_1_2_2_3_1
e_1_2_2_9_1
e_1_2_2_8_1
e_1_2_2_26_1
Davis JM (e_1_2_2_17_1) 2016; 68
e_1_2_2_14_1
e_1_2_2_13_1
e_1_2_2_12_1
e_1_2_2_11_1
Heijde DM. (e_1_2_2_7_1) 1999; 26
e_1_2_2_10_1
e_1_2_2_19_1
e_1_2_2_18_1
e_1_2_2_16_1
e_1_2_2_15_1
Fleischmann R (e_1_2_2_1_1) 2016; 68
Chernoff D (e_1_2_2_21_1) 2016; 68
Pincus T (e_1_2_2_6_1) 2009; 67
27992708 - Arthritis Rheumatol. 2017 Apr;69(4):867-868
27111089 - Arthritis Rheumatol. 2016 Sep;68(9):2083-9
References_xml – volume: 7
  start-page: R796
  year: 2005
  end-page: 806
  article-title: Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
  publication-title: Arthritis Res Ther
– volume: 64
  start-page: 1794
  year: 2012
  end-page: 803
  article-title: Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity
  publication-title: Arthritis Care Res (Hoboken)
– year: 2016
  article-title: Association of the multi‐biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor‐α inhibitor treatment in clinical practice
  publication-title: Mod Rheumatol
– volume: 42
  start-page: 244
  year: 2003
  end-page: 57
  article-title: A Simplified Disease Activity Index for rheumatoid arthritis for use in clinical practice
  publication-title: Rheumatology (Oxford)
– volume: 26
  start-page: 743
  year: 1999
  end-page: 5
  article-title: How to read radiographs according to the Sharp/van der Heijde method [corrected and republished in J Rheumatol 2000;27:261–3]
  publication-title: J Rheumatol
– volume: 52
  start-page: 1202
  year: 2013
  end-page: 7
  article-title: A multi‐biomarker score measures rheumatoid arthritis disease activity in the BeSt study
  publication-title: Rheumatology (Oxford)
– volume: 71
  start-page: 1692
  year: 2012
  end-page: 7
  article-title: Performance of a multi‐biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study
  publication-title: Ann Rheum Dis
– volume: 68
  issue: Suppl 10
  year: 2016
  article-title: Examination of diurnal and daily variation of the Multi‐Biomarker Disease Activity (MBDA) score in RA to establish the minimally important difference [abstract]
  publication-title: Arthritis Rheumatol
– volume: 66
  start-page: 407
  year: 2007
  end-page: 9
  article-title: Comparison of Disease Activity Score (DAS)28‐ erythrocyte sedimentation rate and DAS28‐ C‐reactive protein threshold values
  publication-title: Ann Rheum Dis
– volume: 41
  start-page: 2114
  year: 2014
  end-page: 9
  article-title: A multibiomarker disease activity score for rheumatoid arthritis predicts radiographic joint damage in the BeSt study
  publication-title: J Rheumatol
– year: 2016
– volume: 67
  start-page: 2855
  year: 2015
  end-page: 60
  article-title: Enhancement of patient recruitment in rheumatoid arthritis clinical trials using a multi‐biomarker disease activity score as an inclusion criterion
  publication-title: Arthritis Rheumatol
– volume: 68
  start-page: 2083
  year: 2016
  end-page: 9
  article-title: Estimating disease activity using multi‐biomarker disease activity scores in rheumatoid arthritis patients treated with abatacept or adalimumab. Arthritis
  publication-title: Rheumatol
– volume: 55
  start-page: 357
  year: 2016
  end-page: 66
  article-title: Relationship of multi‐biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis
  publication-title: Rheumatology (Oxford)
– volume: 2
  start-page: e000197
  year: 2016
  article-title: Association of a multibiomarker disease activity score at multiple time‐points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial
  publication-title: RMD Open
– volume: 74
  start-page: 1102
  year: 2015
  end-page: 9
  article-title: Pretreatment multi‐biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial
  publication-title: Ann Rheum Dis
– volume: 5
  start-page: 69
  year: 2015
  end-page: 78
  article-title: A multi‐biomarker disease activity score for monitoring rheumatoid arthritis
  publication-title: Curr Biomark Find
– volume: 67
  start-page: 211
  year: 2009
  end-page: 25
  article-title: RAPID3—an index of physical function, pain, and global status as “vital signs” to improve care for people with chronic rheumatic diseases
  publication-title: Bull NYU Hosp Jt Dis
– volume: 36
  start-page: 1429
  year: 2009
  end-page: 41
  article-title: Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis
  publication-title: J Rheumatol
– volume: 65
  start-page: 28
  year: 2013
  end-page: 38
  article-title: Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a phase IIIb, multinational, prospective, randomized study
  publication-title: Arthritis Rheum
– volume: 70
  start-page: 415
  year: 2012
  end-page: 24
  article-title: Characterization of a multiplex, 12‐biomarker test for rheumatoid arthritis
  publication-title: J Pharm Biomed Anal
– volume: 68
  start-page: 2061
  year: 2016
  end-page: 6
  article-title: The Multi‐Biomarker Disease Activity (MBDA) test for rheumatoid arthritis: is it a valid measure of disease activity? [editorial]. Arthritis
  publication-title: Rheumatol
– volume: 52
  start-page: 839
  year: 2013
  end-page: 46
  article-title: An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression
  publication-title: Rheumatology (Oxford)
– volume: 38
  start-page: 44
  year: 1995
  end-page: 8
  article-title: Modified disease activity scores that include twenty‐eight–joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
  publication-title: Arthritis Rheum
– volume: 74
  start-page: 1132
  year: 2015
  end-page: 7
  article-title: How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?
  publication-title: Ann Rheum Dis
– volume: 73
  start-page: 86
  year: 2014
  end-page: 94
  article-title: Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two year efficacy and safety findings from AMPLE trial
  publication-title: Ann Rheum Dis
– ident: e_1_2_2_5_1
  doi: 10.1093/rheumatology/keg072
– ident: e_1_2_2_25_1
  doi: 10.1002/art.39274
– ident: e_1_2_2_23_1
  doi: 10.1016/j.jpba.2012.06.003
– ident: e_1_2_2_11_1
  doi: 10.1136/annrheumdis-2013-204986
– ident: e_1_2_2_9_1
  doi: 10.1093/rheumatology/kes378
– ident: e_1_2_2_14_1
  doi: 10.1002/acr.21767
– ident: e_1_2_2_3_1
  doi: 10.1002/art.1780380107
– ident: e_1_2_2_20_1
  doi: 10.1136/rmdopen-2015-000197
– ident: e_1_2_2_15_1
  doi: 10.1136/ard.2006.054205
– ident: e_1_2_2_18_1
  doi: 10.1136/annrheumdis-2011-200963
– volume: 68
  issue: 10
  year: 2016
  ident: e_1_2_2_21_1
  article-title: Examination of diurnal and daily variation of the Multi‐Biomarker Disease Activity (MBDA) score in RA to establish the minimally important difference [abstract]
  publication-title: Arthritis Rheumatol
– ident: e_1_2_2_13_1
  doi: 10.3109/14397595.2016.1153449
– ident: e_1_2_2_4_1
  doi: 10.1186/ar1740
– volume: 67
  start-page: 211
  year: 2009
  ident: e_1_2_2_6_1
  article-title: RAPID3—an index of physical function, pain, and global status as “vital signs” to improve care for people with chronic rheumatic diseases
  publication-title: Bull NYU Hosp Jt Dis
– volume: 5
  start-page: 69
  year: 2015
  ident: e_1_2_2_24_1
  article-title: A multi‐biomarker disease activity score for monitoring rheumatoid arthritis
  publication-title: Curr Biomark Find
– ident: e_1_2_2_26_1
– ident: e_1_2_2_10_1
  doi: 10.3899/jrheum.131412
– ident: e_1_2_2_12_1
  doi: 10.1093/rheumatology/kev341
– ident: e_1_2_2_19_1
  doi: 10.1093/rheumatology/kes362
– volume: 26
  start-page: 743
  year: 1999
  ident: e_1_2_2_7_1
  article-title: How to read radiographs according to the Sharp/van der Heijde method [corrected and republished in J Rheumatol 2000;27:261–3]
  publication-title: J Rheumatol
– ident: e_1_2_2_8_1
  doi: 10.3899/jrheum.081018
– ident: e_1_2_2_16_1
  doi: 10.1136/annrheumdis-2013-204920
– volume: 68
  start-page: 2061
  year: 2016
  ident: e_1_2_2_17_1
  article-title: The Multi‐Biomarker Disease Activity (MBDA) test for rheumatoid arthritis: is it a valid measure of disease activity? [editorial]. Arthritis
  publication-title: Rheumatol
– volume: 68
  start-page: 2083
  year: 2016
  ident: e_1_2_2_1_1
  article-title: Estimating disease activity using multi‐biomarker disease activity scores in rheumatoid arthritis patients treated with abatacept or adalimumab. Arthritis
  publication-title: Rheumatol
– ident: e_1_2_2_2_1
  doi: 10.1002/art.37711
– ident: e_1_2_2_22_1
  doi: 10.1136/annrheumdis-2013-203843
– reference: 27111089 - Arthritis Rheumatol. 2016 Sep;68(9):2083-9
– reference: 27992708 - Arthritis Rheumatol. 2017 Apr;69(4):867-868
SSID ssj0000970605
Score 2.2803013
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 863
SubjectTerms Abatacept
Adalimumab
Antirheumatic Agents
Arthritis
Arthritis, Rheumatoid
Biological Products
Biomarkers
Humans
Immunotherapy
Letters
Methotrexate
Monoclonal antibodies
Rheumatoid arthritis
TNF inhibitors
Title Reanalysis of the Multi‐Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic‐Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fart.39981
https://www.ncbi.nlm.nih.gov/pubmed/27813312
https://www.proquest.com/docview/1881783936
https://www.proquest.com/docview/2290649601
https://www.proquest.com/docview/1836727235
https://pubmed.ncbi.nlm.nih.gov/PMC6749941
Volume 69
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEDZVkYAL4lmWFjQgDr1E3Th2HvS0bakKaCtUqNRbZDuONqKboN2sRG_8BH5jf0ln7GxgtUXislrJk_iRmfHM2PMNY-9CqhmSCR1wXepAlFKgzBkbyILMhURZwykbeXwan5yLTxfyYoPtL3NhPD5EH3AjyXD6mgRc6fneH9BQXFl02DNKu75LqbXE5Fx86QMsw4yAYaQrLsfjALsOl8hCQ77XP726H60Zmet3Jf-2Yd0mdPyIPeysRxj5z_2Ybdj6Cbs37s7Hn965f2ZVhzICTQlo3IHLsL3-9fugaqZ0FWcGR_5MBkbGV46ArwRlCWi9gj8Cxt1snaiq3etGWrWKrsIARdoWcxgVaMlPF1Ol4bCvaUjUvsplZbDvU4U6Fc4mFsnapipoAhOHpgSouCgSNAcKCMOBMt8pz6QuYEylrduZ_YnGMNBtx6v31AEFM6HpxuKXAfQVIPtV6KdPVV2DbUFdPmPnxx--HZ4EXbGHwOD-GAZRWhSRGqpColpRiYmlyWJrRCRKjTZVjF5AIjJhI1QaPEpsIpW2RZmpKAlLKhfynG3WTW1fMCginkqjShPGRpRCpZLHJraUpoycp8yA7S4_eW46JHQqyHGZewxnniN35I47BuxtT_rDw3_cRrSz5Ju80wDzPEzTEEeFI7-12cHsC3Qf8ek3fTOKNp3XqNo2C3pF5M7JIzlgW54L-0HgjFHIQj5gyQp_9gQEG77aUlcTBx8e4zpmAvvddZz873nl6FK5Py__n3SbPeBk-Li7TTtss50t7Cs021r92okn_h59_HwDxHRGbA
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1fb9MwEDfTkBgviL-jMOBAPOwlWuPYToN46QZTgbVCY5P2FjmOo0asCWpTib3xEfiMfBLu7DRQdUi8RfIl_pO7893Z9zvGXodUMyQRWcCzIgtEIQXKnLGBzMlciLU1nLKRxxM1OhcfL-TFFnu7yoXx-BBdwI0kw-lrEnAKSB_8QQ3FpUWPPaG865tC8ZgKN3DxuYuw9BNChpGuuhxXAfYdrqCF-vyge3t9Q9qwMjcvS_5txLpd6Pguu9OajzD0__se27LVfXZr3B6QP7ixc2p1CzMCdQFo3YFLsf314-dhWc_oLs4c3vlDGRgaXzoCvhCWJaD5Cv4MGLezTaKycp8bZrrRdBcGKNS2XMAwR1N-tpzpDI66ooZE7ctclgb7nmhUqnA6tUjW1GVOE5g6OCVAzUWhoAVQRBgOtflKiSZVDmOqbd3M7Xe0hoGuO169oQ4omgl1Oxa_DJBdAfJfiY76TFcV2Ab05UN2fvz-7GgUtNUeAoMbZBhEgzyPdF_nEvWKjo2SJlHWiEgUGRpVCt2AWCTCRqg1eBTbWOrM5kWiozgsqF7II7Zd1ZV9zCCP-EAaXZhQGVEIPZBcGWUpTxlZT5se21_98tS0UOhUkeMy9SDOPEXuSB139NirjvSbx_-4jmhvxTdpqwIWaTgYhDgqHPm1zQ5nX6D_iG-_7JpRtunARle2XtInIndQHske2_Vc2A0CZ4xSFvIei9f4syMg3PD1lqqcOvxwheuYCOx333Hyv-eVok_lHp78P-kLtjM6G5-kJx8mn56y25ysIHfRaY9tN_OlfYY2XJM9d6L6G4_GSN8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwEDfTkAYviG8KAw7Ew16iNY6dNPDUbVTjo9U0mLS3yLEdNWJNpjaV2Bt_An8jfwl3dhqoOiTeIvkSf-TufL7z_Y6xNyHVDElFHvC8yANRSIEyp20gDZkLibKaUzbyeBIfn4mP5_J8i71b5cJ4fIjO4UaS4fQ1CfilKfb_gIbiyuKBPaW065sU7CP25uKkc7D0UwKGka64HI8D7DpcIQv1-X739vp-tGFkbt6V_NuGdZvQ6C6701qPMPS_-x7bstV9tjNu4-MPbtw6tapFGYG6ADTuwGXY_vrx86CsZ3QVZw5HPiYDQ-0rR8AXgrIEtF7Bh4BxN9skKiv3uWGuGkVXYYA8bcsFDA1a8rPlTOVw2NU0JGpf5bLU2PdEoU6F06lFsqYuDU1g6tCUABUXeYIWQA5hOFD6G-WZVAbGVNq6mdvvaAwD3Xa8eksdkDMT6nYsfhkgvwJkvxLP6TNVVWAbUBcP2dno_dfD46At9hBo3B_DIBoYE6m-MhLVikp0LHUaWy0iUeRoU8V4CkhEKmyESoNHiU2kyq0pUhUlYUHlQh6x7aqu7BMGJuIDqVWhw1iLQqiB5LGOLaUpI-cp3WN7q1-e6RYJnQpyXGQew5lnyB2Z444ee92RXnr4j-uIdld8k7UaYJGFg0GIo8KRX9vsYPYFHh_x7VddM4o2xWtUZeslfSJycfJI9thjz4XdIHDGKGQh77FkjT87AoINX2-pyqmDD49xHVOB_e45Tv73vDI8UrmHp_9P-pLtnByNss8fJp-esducbCB3zWmXbTfzpX2OFlyTv3CS-htzQEgR
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reanalysis+of+the+Multi%E2%80%90Biomarker+Disease+Activity+Score+for+Assessing+Disease+Activity+in+the+Abatacept+Versus+Adalimumab+Comparison+in+Biologic%E2%80%90Naive+Rheumatoid+Arthritis+Subjects+with+Background+Methotrexate+Study%3A+Comment+on+the+Article+by+Fleischmann+et+al&rft.jtitle=Arthritis+%26+rheumatology+%28Hoboken%2C+N.J.%29&rft.au=Curtis%2C+Jeffrey+R&rft.au=Wright%2C+Grace+C&rft.au=Strand%2C+Vibeke&rft.au=Davis%2C+Charles+S&rft.date=2017-04-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=2326-5191&rft.eissn=2326-5205&rft.volume=69&rft.issue=4&rft.spage=863&rft.epage=865&rft_id=info:doi/10.1002%2Fart.39981&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2326-5191&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2326-5191&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2326-5191&client=summon